Our Mission

Adverum is a clinical-stage gene therapy company targeting unmet medical need in ocular and rare diseases. We develop gene therapy product candidates designed to provide durable efficacy by inducing sustained expression of a therapeutic protein. Our core capabilities include clinical development, novel vector discovery, and in-house manufacturing expertise, specifically in scalable process development, assay development, and current Good Manufacturing Practices (cGMP) quality control. Our team has extensive clinical development experience and is laser-focused on advancing novel gene therapies for patients.

Core Values

At Adverum, our values underscore our business and shape how we think of the patients we hope to help, how we apply science to medicine, and how we work and grow as a company.

INTEGRITY We are honest with our purpose, courageous against the unknown, and genuine through communications. RESPECT, TRANSPARENCY, HONESTY
COMMUNITY We collaborate as a team to solve difficult problems, and support one another in these endeavors. COLLABORATE TO BREAK BARRIERS
EMPOWERMENT We bring our best selves to take ownership, be accountable, learn, grow, and achieve success. FREEDOM TO FULFILL INDIVIDUAL POSSIBILITIES
PATIENT FOCUSED We are humbled and inspired by our patients, with sincere empathy as we strive to understand their individual journeys. PUT THE PATIENT FIRST
PIONEERING We are not afraid to create new paths forward, leveraging our passion, grit, and resilience in doing so. EXPLORE TO CREATE POSSIBILITY

Our Leadership Team

Print All
Laurent Fischer, M.D. Chief Executive Officer
Leone Patterson President and Chief Financial Officer
Julie Clark, M.D. Chief Medical Officer
Christopher J. DeRespino Chief Business Officer
Brigit Riley, Ph.D. Chief Scientific Officer
Peter Soparkar, J.D. Chief Legal Officer
Angela Thedinga, MBA, MPH Chief Technology Officer
Amy Figueroa, CFA Vice President, Investor Relations and Corporate Communications
Dena House Vice President, Human Resources
Thomas Kochy Vice President, Commercial and
Program Strategy
Michael Steel Vice President, Quality
Patrick Machado, J.D. Board Chair
Laurent Fischer, M.D. Director
Mehdi Gasmi, Ph.D. Director
Mark Lupher, Ph.D. Director
James Scopa, J.D., M.B.A. Director
Dawn Svoronos Director
Reed V. Tuckson, M.D. Director
Scott M. Whitcup, M.D. Director
Thomas F. Woiwode, Ph.D. Director
David S. Boyer, M.D. Scientific Advisory Board Member
Jeffrey Heier, M.D. Scientific Advisory Board Member
Arshad M. Khanani, M.D., M.A. Scientific Advisory Board Member
Szilárd Kiss, M.D. Scientific Advisory Board Member
Charles C. Wykoff, M.D., Ph.D. Scientific Advisory Board Member

Contact Us

Adverum Biotechnologies, Inc., 800 Saginaw Drive, Redwood City, CA 94063
Tel: 650-656-9323 General Inquiry: info@adverum.com

  • *Indicates required field